Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· April 17, 2026

S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease

View original at nasdaq.com
S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease The S&P 500 Index ($SPX) (SPY) today is up +1.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +2.07%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.326%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Risks to the price outlook are tilted to the upside, especially in the near term, while the medium-term implications will depend on the intensity and duration of the war

    60% confidence
  • Iran made key concessions in an ongoing negotiation to end the seven-week war

    60% confidence
  • Q1 S&P 500 earnings projected to climb +12% y/y, and stripping out the technology sector, Q1 earnings are projected to increase around +3%, the weakest in two years

    60% confidence
  • The US and Iran are negotiating over a plan to end the war, with one element under discussion being that the US would release $20 billion in frozen Iranian assets in return for Iran giving up its stockpile of enriched uranium

    60% confidence
  • The US naval blockade in the Strait of Hormuz will remain in full force until a deal is fully agreed

    60% confidence
  • President Trump might travel to Pakistan if a deal with Iran is clinched

    60% confidence
  • The ECB needs to stay vigilant to potential inflation risks from the Iran war, but there is no obvious case to raise rates

    60% confidence
  • June is a better moment than April to decide whether an ECB interest rate response to the Iran war is necessary

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com